Video

How New Regulatory Requirements Have Affected Controlled Dangerous Substance Dispensing

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.

Karen Ryle, MS, RPh, associate chief of pharmacy at Massachusetts General Hospital, discusses how new regulatory requirements have affected controlled dangerous substance dispensing.

This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.

Related Videos
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
3D rendering of multiple myeloma cancer cells | Image Credit: © Сергей Косилко - stock.adobe.com
fda on paper texture - Image credit: Araki Illustrations | stock.adobe.com
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
Related Content
Newborn baby monitored for seizures -- Image credit: stockphoto mania | stock.adobe.com
February 14th 2025

The Role of Pharmacists in Optimizing Care for Seizures in Neonatal Patients

Gillian McGovern, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Patient with psoriasis, psoriatic arthritis -- Image credit: Ольга Тернавская | stock.adobe.com
February 14th 2025

Pharmacists Play a Crucial Role Monitoring Patients With Psoriasis and Psoriatic Arthritis

Gillian McGovern, Associate Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
Clogged arteries, Cholesterol plaque in the artery
February 13th 2025

FDA Accepts BLA for Lerodalcibep, a Novel Agent to Lower LDL Cholesterol in Atherosclerotic Cardiovascular Disease

Luke Halpern, Assistant Editor
AI depiction of an older woman's eyes | Image Credit: © nabila - stock.adobe.com
Published: February 13th 2025 | Updated: February 13th 2025

Expanded Label for Avacincaptad Pegol Intravitreal Solution Receives FDA Approval

Alexandra Gerlach, Associate Editor